Microglia response and P2 receptor participation in oxygen/glucose deprivation-induced cortical damage

F Cavaliere1, K Dinkel, K Reymann

  • 1Research Institute for Applied Neuroscience, FAN GmbH, Leipziger Str., 44, D-39120 Magdeburg, Germany. f.cavaliere@nsantalucia.it

Neuroscience
|December 14, 2005
PubMed

Insights

Resident microglia and P2X4/P2X7 receptors contribute to brain damage after oxygen/glucose deprivation. Purinergic antagonists like TNP-ATP and PPADS show neuroprotective effects, suggesting potential therapeutic applications.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Microglia, the resident immune cells of the brain, play a critical role in neuroinflammation.
  • Oxygen/glucose deprivation (OGD) is a major cause of ischemic stroke and neuronal damage.
  • P2 receptors are involved in cellular signaling and immune responses.

Purpose of the Study:

  • To investigate the role of microglia in OGD-induced brain injury.
  • To identify the expression and modulation of P2 receptors on microglia during OGD.
  • To explore the therapeutic potential of P2 receptor antagonists.

Main Methods:

  • Organotypic cortical/striatal/subventricular zone slice model.
  • Immunofluorescence staining with microglial marker OX42.
  • Pharmacological treatments with P2 agonists and antagonists (indomethacin, TNP-ATP, PPADS).
  • Co-culture experiments with N9 microglia cell line.

Main Results:

  • Microglia activation and recruitment correlate with cellular loss in the cortex after OGD.
  • P2X4 and P2X7 receptors are expressed on microglia and upregulated during OGD.
  • P2 agonists exacerbate OGD-induced damage, while antagonists TNP-ATP and PPADS show neuroprotection.
  • Co-culturing with N9 microglia increased cortical damage, which was reduced by PPADS.

Conclusions:

  • Microglia activation and P2X4/P2X7 receptor signaling contribute to OGD-induced neurotoxicity.
  • Purinergic antagonists demonstrate neuroprotective effects, indicating a potential therapeutic strategy for OGD-related conditions.

Related Concept Videos